Latest update

Our Latest Update

Explore latest news and research updates at Togontech.

  • News

    Lutz Gieselmann Honored with Robert Koch Postdoctoral Award

    We are delighted to congratulate Lutz Gieselmann on receiving the Robert Koch Postdoctoral Prize in Immunology. Awarded by the Robert Koch Foundation in cooperation with the German Society for Immunology, the prize recognizes outstanding early-career research that substantially improves our understanding of infectious diseases and contributes to advances in diagnosis, therapy, or new strategies to combat them. A prestigious recognition of impactful immunology research. Congratulations, Lutz!

    Learn more
  • News

    Togontech Launches Its New Brand Identity and Website

    We’re pleased to introduce Togontech’s new brand identity and website, a refreshed digital presence that reflects our mission, our science, and our vision for the future. This project was brought to life through the collaboration of a talented team. Special thanks to Marco Grimaldi for the design direction, Oriana Gaeta for her creative contribution, Patrick Heintzmann for the development, and Klaus Dyba for the portrait photography.

  • PRESS RELEASE

    HIV Antibody Opens New Approaches for Vaccine Development and Combination Therapies

    Togontech supports the preclinical development of HIV antibody 007, advancing new possibilities for combination therapies and vaccine development. Source: University of Cologne

    Read Original Article
  • Publication

    Broadly Neutralizing Antibody 007 Published in Nature Immunology

    Our new Nature Immunology publication introduces 007, a novel broadly neutralizing antibody targeting the HIV-1 V3 glycan site. The findings open new opportunities for antibody-based therapies and vaccine design.

    Visit Link
  • News

    Welcoming Ivanna Marchesini to Our Scientific Team

    We’re happy to welcome Ivanna Marchesini to Togontech’s Team. Ivanna joins us to support our translational research and laboratory activities, bringing scientific curiosity, precision, and a collaborative spirit.

    Visit Link
  • Publication

    Discovery of Broadly Neutralizing Antibody 04_A06 Published in Nature Immunology

    Nature Immunology published our discovery of broadly neutralizing HIV-1 antibody 04_A06, one of the broadest and most potent CD4 binding site antibodies identified to date.

    Visit Link
  • News

    Collaborating with the V3ECTORY HCV Vaccine Programme

    Togontech will collaborate with researchers at TWINCORE on the V3ECTORY HCV Vaccine Programme, bringing its expertise to support next-generation HCV vaccine development.

    Visit Link
  • News

    Togontech Opens Its First Laboratory

    Located in the city of Cologne, Germany, this new establishment is set to enhance the company's research capabilities and foster innovation in various technological fields.

Shape the Future of Antibody Therapies

PartnershipsDevelopmentOpportunities

Whether you are interested in our single-cell discovery platform or exploring co-development opportunities, our team is ready to provide the technical expertise and strategic agility your pipeline requires.

Partner with us